1 1600 119 MEDIYOGA AS A PART OF A SELF-MANAGEMENT PROGRAMME AMONG PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION - A RANDOMISED STUDY. BACKGROUND: PAROXYSMAL ATRIAL FIBRILLATION IS ASSOCIATED WITH IMPAIRED HEALTH-RELATED QUALITY OF LIFE. YOGA HAS BEEN SUGGESTED TO IMPROVE HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS WITH HEART FAILURE AND HYPERTENSION. AIM: THE AIM OF THE STUDY WAS TO EVALUATE THE EFFECTS OF MEDIYOGA, IN RESPECT OF HEALTH-RELATED QUALITY OF LIFE, BLOOD PRESSURE, HEART RATE, AS WELL AS N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE, AMONG PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION, COMPARED WITH STANDARD THERAPY OR RELAXATION. METHODS: PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION, N=132, WERE STRATIFIED FOR GENDER AND RANDOMISED TO MEDIYOGA, A RELAXATION GROUP OR A CONTROL GROUP, 44 PATIENTS PER GROUP WITH A 12-WEEK FOLLOW-UP. HEALTH-RELATED QUALITY OF LIFE, BLOOD PRESSURE, HEART RATE AND N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE WERE ASSESSED. RESULTS: AFTER 12 WEEKS, THERE WERE NO DIFFERENCES IN HEALTH-RELATED QUALITY OF LIFE BETWEEN THE GROUPS. THERE WERE IMPROVEMENTS IN SHORT-FORM HEALTH SURVEY BODILY PAIN, GENERAL HEALTH, SOCIAL FUNCTION, MENTAL HEALTH AND MENTAL COMPONENT SUMMARY SCORES WITHIN THE MEDIYOGA GROUP (P=0.014, P=0.037, P=0.029, P=0.030, P=0.019, RESPECTIVELY). NO CHANGE WAS SEEN IN THE RELAXATION AND CONTROL GROUPS. SYSTOLIC BLOOD PRESSURE DECREASED IN THE MEDIYOGA GROUP (134+/-18 TO 127+/-13) COMPARED WITH THE CONTROL GROUP (126+/-17 TO 127+/-15, P=0.041); NO DIFFERENCE COMPARED WITH THE RELAXATION GROUP (131+/-17 TO 125+/-12). DIASTOLIC BLOOD PRESSURE DECREASED IN THE MEDIYOGA GROUP (79+/-9 TO 74 +/-9) COMPARED WITH THE CONTROL GROUP (76+/-9 TO 79+/-8, P=0.005); NO DIFFERENCE COMPARED WITH THE RELAXATION GROUP (76+/-9 TO 77+/-8). THERE WERE NO DIFFERENCES IN HEART RATE AND N-TERMINAL PRO B-TYPE NATRIURETIC PEPTIDE BETWEEN THE GROUPS AFTER 12 WEEKS. CONCLUSIONS: MEDIYOGA IMPROVES HEALTH-RELATED QUALITY OF LIFE AND DECREASES BLOOD PRESSURE IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION. MEDIYOGA MAY BE USED AS A PART OF A SELF-MANAGEMENT PROGRAMME AMONG PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION. 2020 2 2228 20 THE IMPACT OF YOGA ON ATRIAL FIBRILLATION: A REVIEW OF THE YOGA MY HEART STUDY. ATRIAL FIBRILLATION IS A COMMON ARRHYTHMIA AFFECTING THOUSANDS OF INDIVIDUALS WORLDWIDE. IT IS A CONDUCTION DISORDER THAT CAUSES THE HEART TO BEAT IRREGULARLY AND RAPIDLY. THERE ARE A FEW MEDICAL APPROACHES TO MANAGE THIS COSTLY HEALTH CARE BURDEN: ANTIARRHYTHMICS TO MAINTAIN NORMAL SINUS RHYTHM, BETA BLOCKERS TO ACHIEVE RATE CONTROL WHILE ALLOWING ATRIAL FIBRILLATION TO PERSIST, AND ELECTRO-PHYSIOLOGIC INTERVENTION FOR RATE AND RHYTHM CONTROL. THESE TREATMENTS CAN BE COSTLY AND ARE NOT WITHOUT SIDE EFFECTS. YOGA, AN INTERVENTION THAT IS AVAILABLE TO PEOPLE WORLDWIDE, HAS SHOWN SOME PROMISE IN COMBATING THIS WIDESPREAD HEART DISORDER. 2015 3 1721 33 PERCEPTIONS AND EXPERIENCES OF MEDIYOGA AMONG PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION-AN INTERVIEW STUDY. OBJECTIVES: WE INVESTIGATED THE PERCEPTIONS AND EXPERIENCES OF A THERAPEUTIC YOGA FORM, MEDIYOGA, WHICH IS EVOLVED FROM KUNDALINIYOGA AMONG PATIENTS WITH SYMPTOMATIC PAROXYSMAL ATRIAL FIBRILLATION (PAF). DESIGN AND SETTING: AN INDUCTIVE EXPLORATORY DESIGN WAS CHOSEN WITH INDIVIDUAL SEMI-STRUCTURED INTERVIEWS. THE STUDY WAS CONDUCTED WITH 12 PARTICIPANTS (7 MEN AND 5 WOMEN, AVERAGE AGE 63.5) AT A UNIVERSITY HOSPITAL, SWEDEN. INFORMED CONSENT WAS OBTAINED FROM ALL PARTICIPANTS. THE DATA WERE ANALYZED USING A QUALITATIVE CONTENT ANALYSIS WITH AN INDUCTIVE METHOD AND A MANIFEST APPROACH. RESULTS: THREE CATEGORIES WERE FOUND IN THE ANALYSIS. IN THE CATEGORY "A TIME FOR A SENSE OF EXISTENCE AND PRESENCE", THE PATIENTS DESCRIBED AN INCREASED THOUGHTFULNESS AND EXPERIENCES OF GAINING ACCESS TO AN INNER SELF. THE CATEGORY "A WAY OF GAINING WELL-BEING AND INCREASED CONSCIOUSNESS" DESCRIBES PATIENTS` FEELINGS OF RELAXATION AND FEELING OF COMFORT, WITH COMPONENTS OF MENTAL AND PHYSICAL WELL-BEING. FURTHERMORE, "ACCESS TO A TOOL TO GAIN WILLPOWER AND RELIEVE SYMPTOMS" DESCRIBES THE PERCEPTIONS FROM PATIENTS TO OBTAINED ACCESS TO A TOOL FOR HANDLING THE EMOTIONS, SUCH AS FEAR AND ANXIETY, AS WELL AS SYMPTOMS THAT THEY COULD STRUGGLING WITH BETWEEN, AND DURING, THEIR EPISODES OF ATRIAL FIBRILLATION. NO ADVERSE EVENTS WERE REPORTED BY THE YOGA GROUP, DURING THE STUDY. CONCLUSIONS: PATIENTS WITH PAF DESCRIBED MEDIYOGA AS AN ACCESSIBLE TOOL TO MANAGE EMOTIONS AND SYMPTOMS RELATED TO EPISODES OF AF. MEDIYOGA MAY ALSO ASSIST IN ENHANCING BODY AWARENESS, WHEREBY PHYSICAL, MENTAL AND SPIRITUAL COMPONENTS ARE INTEGRATED. MEDIYOGA MAY STRENGTHEN SELF-MANAGEMENT AMONG PATIENTS WITH PAF. 2018 4 1039 58 EFFECTS OF YOGA IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION - A RANDOMIZED CONTROLLED STUDY. BACKGROUND: PATIENTS WITH ATRIAL FIBRILLATION OFTEN HAVE AN IMPAIRED QUALITY OF LIFE (QOL). PRACTISING YOGA MAY DECREASE STRESS AND HAVE POSITIVE EFFECTS ON MENTAL AND PHYSICAL HEALTH. THE AIM OF THIS STUDY WAS TO INVESTIGATE WHETHER YOGA CAN IMPROVE QOL AND DECREASE BLOOD PRESSURE AND HEART RATE IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION (PAF). METHODS: IN THIS PILOT STUDY, 80 PATIENTS DIAGNOSED WITH PAF WERE RANDOMIZED TO STANDARD TREATMENT (CONTROL GROUP, N=40) OR STANDARD TREATMENT IN COMBINATION WITH YOGA (YOGA GROUP, N=40) DURING A 12-WEEK PERIOD. QOL, BLOOD PRESSURE AND HEART RATE WERE EVALUATED AT BASELINE AND AT THE END OF THE STUDY (12 (+2) WEEKS). EUROQOL-5D (EQ-5D) VISUAL ANALOGUE SCALE (VAS) AND THE TWO DIMENSIONS IN SHORT-FORM HEALTH SURVEY (SF-36) WERE USED TO EVALUATE QOL. RESULTS: AT BASELINE THERE WAS A SIGNIFICANT DIFFERENCE IN QOL BETWEEN THE GROUPS IN EQ-5D VAS- SCALE ( P=0.02) AND SF-36 MENTAL HEALTH SCORE ( P<0.001) IN WHICH THE CONTROL GROUP HAD HIGHER SCORES. AT THE END OF THE STUDY, THE YOGA GROUP AVERAGED HIGHER SF-36 MENTAL HEALTH SCORES. THERE WAS A SIGNIFICANT DIFFERENCE BETWEEN THE TWO GROUPS ( P=0.016), BUT NO DIFFERENCES IN EQ-5D VAS- SCALE AND PHYSIOLOGICAL HEALTH SCORE WAS SEEN BETWEEN THE TWO GROUPS. AT THE END OF THE STUDY, THE YOGA GROUP HAD SIGNIFICANTLY LOWER HEART RATE ( P=0.024) AND SYSTOLIC ( P=0.033) AND DIASTOLIC BLOOD PRESSURE ( P<0.001) COMPARED TO THE CONTROL GROUP. CONCLUSIONS: YOGA WITH LIGHT MOVEMENTS AND DEEP BREATHING MAY LEAD TO IMPROVED QOL, LOWER BLOOD PRESSURE AND LOWER HEART RATE IN PATIENTS WITH PAF COMPARED TO A CONTROL GROUP. YOGA COULD BE A COMPLEMENTARY TREATMENT METHOD TO STANDARD THERAPY. 2017 5 807 44 EFFECT OF YOGA ON ARRHYTHMIA BURDEN, ANXIETY, DEPRESSION, AND QUALITY OF LIFE IN PAROXYSMAL ATRIAL FIBRILLATION: THE YOGA MY HEART STUDY. OBJECTIVES: THE PURPOSE OF THIS STUDY WAS TO EXAMINE THE IMPACT OF YOGA ON ATRIAL FIBRILLATION (AF) BURDEN, QUALITY OF LIFE (QOL), DEPRESSION, AND ANXIETY SCORES. BACKGROUND: YOGA IS KNOWN TO HAVE SIGNIFICANT BENEFIT ON CARDIOVASCULAR HEALTH. THE EFFECT OF YOGA IN REDUCING AF BURDEN IS UNKNOWN. METHODS: THIS SINGLE-CENTER, PRE-POST STUDY ENROLLED PATIENTS WITH SYMPTOMATIC PAROXYSMAL AF WITH AN INITIAL 3-MONTH NONINTERVENTIONAL OBSERVATION PERIOD FOLLOWED BY TWICE-WEEKLY 60-MIN YOGA TRAINING FOR NEXT 3 MONTHS. AF EPISODES DURING THE CONTROL AND STUDY PERIODS AS WELL AS SF-36, ZUNG SELF-RATED ANXIETY, AND ZUNG SELF-RATED DEPRESSION SCORES AT BASELINE, BEFORE, AND AFTER THE STUDY PHASE WERE ASSESSED. RESULTS: YOGA TRAINING REDUCED SYMPTOMATIC AF EPISODES (3.8 +/- 3 VS. 2.1 +/- 2.6, P < 0.001), SYMPTOMATIC NON-AF EPISODES (2.9 +/- 3.4 VS. 1.4 +/- 2.0; P < 0.001), ASYMPTOMATIC AF EPISODES (0.12 +/- 0.44 VS. 0.04 +/- 0.20; P < 0.001), AND DEPRESSION AND ANXIETY (P < 0.001), AND IMPROVED THE QOL PARAMETERS OF PHYSICAL FUNCTIONING, GENERAL HEALTH, VITALITY, SOCIAL FUNCTIONING, AND MENTAL HEALTH DOMAINS ON SF-36 (P = 0.017, P < 0.001, P < 0.001, P = 0.019, AND P < 0.001, RESPECTIVELY). THERE WAS SIGNIFICANT DECREASE IN HEART RATE, AND SYSTOLIC AND DIASTOLIC BLOOD PRESSURE BEFORE AND AFTER YOGA (P < 0.001). CONCLUSIONS: IN PATIENTS WITH PAROXYSMAL AF, YOGA IMPROVES SYMPTOMS, ARRHYTHMIA BURDEN, HEART RATE, BLOOD PRESSURE, ANXIETY AND DEPRESSION SCORES, AND SEVERAL DOMAINS OF QOL. 2013 6 205 29 A REVIEW ON ROLE OF YOGA IN THE MANAGEMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS. EVIDENCE SUGGESTS THAT YOGA IS SAFE AND EFFECTIVE IN IMPROVING VARIOUS RISK FACTORS, QUALITY OF LIFE (QOL), AND PSYCHOLOGICAL BURDEN THAT IS RELATED TO ARRHYTHMIA. HOWEVER, THIS IS THE FIRST-EVER SYSTEMATIC REVIEW PERFORMED TO REPORT THE ROLE OF YOGA IN ARRHYTHMIA. WE HAVE PERFORMED A LITERATURE SEARCH USING COCHRANE LIBRARY, MEDLINE/PUBMED, WEB OF SCIENCE CORE COLLECTION, AND INDMED ELECTRONIC DATABASES UP TO 3, JANUARY 2018. OF 240 ARTICLES, 6 POTENTIALLY ELIGIBLE ARTICLES WERE IDENTIFIED AND INCLUDED IN THE REVIEW. RESULTS SHOWED THAT YOGA COULD BE CONSIDERED AN EFFICIENT ADJUVANT IN REDUCING ARRHYTHMIA (PAROXYSMAL ATRIAL FIBRILLATION, VENTRICULAR TACHYARRHYTHMIA, AND PALPITATION) RELATED HEALTH PROBLEMS; BLOOD PRESSURE, HEART RATE, DEPRESSION AND ANXIETY SCORES; AND IN IMPROVING HEALTH-RELATED QOL OF ARRHYTHMIA PATIENTS. HOWEVER, THERE IS A LACK OF RANDOMIZED CONTROLLED TRIALS AND A CLEAR MECHANISM BEHIND THE EFFECT OF YOGA; STUDIES HAD RELATIVELY A SMALL SAMPLE SIZE AND DIFFERENT YOGA PROTOCOLS. 2021 7 299 22 ALTERNATIVE MEDICINE IN ATRIAL FIBRILLATION TREATMENT-YOGA, ACUPUNCTURE, BIOFEEDBACK AND MORE. THE LAST DECADE HAS SEEN A SIGNIFICANT IMPROVEMENT IN THE MANAGEMENT OF ATRIAL FIBRILLATION (AF) WITH THE DEVELOPMENT OF NEWER MEDICATIONS AND IMPROVEMENT IN CATHETER ABLATION TECHNIQUES. RECURRENCE OF AF REMAINS A SIGNIFICANT PROBLEM IN THESE PATIENTS AND MEDICATIONS OFFER LIMITED SUPPORTIVE ROLE. COMPLEMENTARY AND ALTERNATIVE TREATMENT STRATEGIES THEREFORE REMAIN A VIABLE OPTION FOR THESE AF PATIENTS. SEVERAL STUDIES HAVE SHOWN IMPROVEMENT IN AF SYMPTOMS WITH YOGA THERAPY, ACUPUNCTURE AND BIOFEEDBACK. THERE ARE ALSO SEVERAL HERBAL MEDICINE AND SUPPLEMENTS SUCH AS OMEGA-3 FATTY ACIDS, ANTIOXIDANT VITAMINS, BARBERRY, MOTHERWORT, CINCHONA, SHENSONGYANGXIN, HAWTHORN, KELLA AND WENXIN KELI THAT HAVE BEEN EVALUATED AS POTENTIAL THERAPEUTIC OPTIONS IN AF. THESE STUDIES ARE HOWEVER LIMITED BY SMALL SAMPLE SIZES WITH MIXED RESULTS. BESIDES THE PHARMACOLOGICAL ACTION, METABOLISM, INTERACTIONS WITH OTHER MEDICATIONS AND THE ADVERSE EFFECTS OF THE HERBAL MEDICATIONS AND SUPPLEMENTS REMAIN POORLY UNDERSTOOD. IN SPITE OF THE ABOVE LIMITATIONS, COMPLEMENTARY THERAPIES REMAIN A PROMISING OPTION IN THE MANAGEMENT OF AF AND FURTHER STUDIES ARE NECESSARY TO VALIDATE THEIR SAFETY AND EFFICACY. 2015 8 2416 25 YOGA AND MEDITATION IN CARDIOVASCULAR DISEASE. YOGA IS A HOLISTIC MIND-BODY INTERVENTION AIMED AT PHYSICAL, MENTAL, EMOTIONAL AND SPIRITUAL WELL BEING. SEVERAL STUDIES HAVE SHOWN THAT YOGA AND/OR MEDITATION CAN CONTROL RISK FACTORS FOR CARDIOVASCULAR DISEASE LIKE HYPERTENSION, TYPE II DIABETES AND INSULIN RESISTANCE, OBESITY, LIPID PROFILE, PSYCHOSOCIAL STRESS AND SMOKING. SOME RANDOMIZED STUDIES SUGGEST THAT YOGA/MEDITATION COULD RETARD OR EVEN REGRESS EARLY AND ADVANCED CORONARY ATHEROSCLEROSIS. A RECENT STUDY SUGGESTS THAT TRANSCENDENTAL MEDITATION MAY BE EXTREMELY USEFUL IN SECONDARY PREVENTION OF CORONARY HEART DISEASE AND MAY REDUCE CARDIOVASCULAR EVENTS BY 48% OVER A 5-YEAR PERIOD. ANOTHER SMALL STUDY SUGGESTS THAT YOGA MAY BE HELPFUL IN PREVENTION OF ATRIAL FIBRILLATION. HOWEVER, MOST STUDIES HAVE SEVERAL LIMITATIONS LIKE LACK OF ADEQUATE CONTROLS, SMALL SAMPLE SIZE, INCONSISTENCIES IN BASELINE AND DIFFERENT METHODOLOGIES, ETC. AND THEREFORE LARGE TRIALS WITH IMPROVED METHODOLOGIES ARE REQUIRED TO CONFIRM THESE FINDINGS. HOWEVER, IN VIEW OF THE EXISTING KNOWLEDGE AND YOGA BEING A COST-EFFECTIVE TECHNIQUE WITHOUT SIDE EFFECTS, IT APPEARS APPROPRIATE TO INCORPORATE YOGA/MEDITATION FOR PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE. 2014 9 1941 42 SAFETY AND EFFICACY OF AYURVEDIC INTERVENTIONS AND YOGA ON LONG TERM EFFECTS OF COVID-19: A STRUCTURED SUMMARY OF A STUDY PROTOCOL FOR A RANDOMIZED CONTROLLED TRIAL. OBJECTIVES: PRIMARY OBJECTIVE * TO ASSESS THE EFFICACY OF AYURVEDA INTERVENTIONS AND YOGA IN REHABILITATION OF COVID-19 CASES SUFFERING WITH LONG TERM EFFECTS OF COVID 19 AS COMPARED TO WHO REHABILITATION SELF-MANAGEMENT AFTER COVID-19- RELATED ILLNESS. SECONDARY OBJECTIVE * TO ASSESS THE SAFETY OF AYURVEDIC INTERVENTIONS IN CASES SUFFERING WITH LONG TERM EFFECTS OF COVID 19 TRIAL DESIGN: MULTI-CENTRIC, RANDOMIZED, CONTROLLED, PARALLEL GROUP, OPEN-LABEL, EXPLORATORY STUDY. THE STUDY DURATION IS 9 MONTHS AND THE INTERVENTION PERIOD IS 90 DAYS FROM THE DAY OF ENROLMENT OF THE PARTICIPANT. PARTICIPANTS: PATIENTS OF EITHER SEX BETWEEN 18 TO 60 YEARS, AMBULATORY, WILLING TO PARTICIPATE, WITH HISTORY (NOT MORE THAN 4 WEEKS) OF POSITIVE RT-PCR FOR COVID-19 OR IGM ANTIBODIES POSITIVITY FOR SARS COV-2, BUT HAVING NEGATIVE RT-PCR FOR COVID-19 AT THE TIME OF SCREENING WILL BE CONSIDERED ELIGIBLE FOR ENROLMENT IN THE STUDY. CRITICALLY ILL PATIENTS WITH ARDS (ACUTE RESPIRATORY DISTRESS SYNDROME), REQUIRING INVASIVE RESPIRATORY SUPPORT IN THE INTENSIVE CARE UNIT, KNOWN CASE OF ANY MALIGNANCY, IMMUNE-COMPROMISED STATE (E.G. HIV), DIABETES MELLITUS, ACTIVE PULMONARY TUBERCULOSIS, PAST HISTORY OF ANY CHRONIC RESPIRATORY DISEASE, MOTOR NEURON DISEASE, MULTIPLE SCLEROSIS, STROKE, IMPAIRED COGNITION, ATRIAL FIBRILLATION, ACUTE CORONARY SYNDROME, MYOCARDIAL INFARCTION, SEVERE ARRHYTHMIA, CONCURRENT SERIOUS HEPATIC DISEASE OR RENAL DISEASE, PREGNANT OR LACTATING WOMEN, PATIENTS ON IMMUNOSUPPRESSIVE MEDICATIONS, HISTORY OF HYPERSENSITIVITY TO THE TRIAL DRUGS OR THEIR INGREDIENTS, DEPRESSIVE ILLNESS (BEFORE COVID-19), DIAGNOSED PSYCHOTIC ILLNESSES, SUBSTANCE DEPENDENCE OR ALCOHOLISM WILL BE EXCLUDED. THE TRIAL WILL BE CONDUCTED AT TWO MEDICAL COLLEGES IN MAHARASHTRA, INDIA. INTERVENTION AND COMPARATOR: INTERVENTION ARM (GROUP-I): AYURVEDA INTERVENTIONS INCLUDING AGASTYA HARITAKI SIX GRAM AND ASHWAGANDHA TABLET 500 MG TWICE DAILY ORALLY AFTER MEALS WITH WARM WATER AND TWO SESSIONS OF YOGA (MORNING 30 MINUTES AND EVENING 15 MINUTES) DAILY FOR 90 DAYS, AS PER THE POST-COVID-19 CARE PROTOCOL PROVIDED IN NATIONAL CLINICAL MANAGEMENT PROTOCOL BASED ON AYURVEDA AND YOGA FOR MANAGEMENT OF COVID-19 PUBLISHED BY MINISTRY OF AYUSH, GOVERNMENT OF INDIA. COMPARATOR ARM (GROUP-II): WHO REHABILITATION SELF-MANAGEMENT AFTER COVID-19 RELATED ILLNESS FOR 90 DAYS. THE TRIAL DRUGS ARE BEING PROCURED FROM A GMP CERTIFIED PHARMACEUTICAL COMPANY. MAIN OUTCOMES: PRIMARY OUTCOME: CHANGE IN RESPIRATORY FUNCTION TO BE ASSESSED BY SAN DIEGO SHORTNESS OF BREATH QUESTIONNAIRE, 6-MINUTES WALK TEST AND PULMONARY FUNCTION TEST. SECONDARY OUTCOMES: CHANGE IN HIGH-RESOLUTION COMPUTED TOMOGRAPHY (HRCT) CHEST CHANGE IN FATIGUE SCORE ASSESSED BY MODIFIED FATIGUE IMPACT SCALE CHANGE IN ANXIETY SCORE ASSESSED BY HOSPITAL ANXIETY AND DEPRESSION SCALE SCORE CHANGE IN SLEEP QUALITY ASSESSED BY PITTSBURGH SLEEP QUALITY INDEX CHANGE IN THE QUALITY OF LIFE ASSESSED BY COV19-QOL SCALE SAFETY OF THE INTERVENTIONS WILL BE ASSESSED BY COMPARING HEMATOLOGICAL AND BIOCHEMICAL INVESTIGATIONS BEFORE AND AFTER THE INTERVENTION PERIOD AND ADVERSE EVENT/ ADVERSE DRUG REACTION TIMELINES FOR OUTCOME ASSESSMENT: SUBJECTIVE PARAMETERS AND CLINICAL ASSESSMENT WILL BE ASSESSED AT BASELINE, 15(TH) DAY, 30(TH) DAY, 60(TH) DAY AND 90(TH) DAY. LABORATORY PARAMETERS (CBC, LFT, KFT, HBA1C, HS-CRP, D-DIMER), PULMONARY FUNCTION TEST AND HRCT CHEST WILL BE DONE AT BASELINE AND AFTER COMPLETION OF STUDY PERIOD I.E. 90(TH) DAY. RANDOMISATION: STATISTICAL PACKAGE FOR SOCIAL SCIENCES (SPSS) VERSION 15.0 IS USED TO GENERATE THE RANDOM NUMBER SEQUENCES. THE PARTICIPANTS WILL BE RANDOMIZED TO TWO STUDY GROUPS IN THE RATIO OF 1:1. BLINDING (MASKING): THE STUDY IS OPEN-LABEL DESIGN. HOWEVER, THE OUTCOME ASSESSOR WILL BE KEPT BLINDED REGARDING THE STUDY GROUP ALLOCATION OF THE PARTICIPANTS. NUMBERS TO BE RANDOMISED (SAMPLE SIZE) SAMPLE SIZE: THE SAMPLE SIZE FOR THE STUDY IS CALCULATED ASSUMING IMPROVEMENT IN 6-MINUTES WALK TEST BY 40 METER IN GROUP I AND A CHANGE OF 10 METER IN GROUP II WITH A STANDARD DEVIATION OF 50 METER BASED ON THE RESULTS OF THE PREVIOUS STUDIES, WITH 95% CONFIDENCE LEVEL (ALPHA = 0.05) AND 80% POWER AND EXPECTING A DROPOUT RATE OF 20%. THE NUMBER OF PARTICIPANTS TO BE ENROLLED IN THE STUDY SHOULD BE APPROXIMATELY 55 IN EACH GROUP. HENCE, A TOTAL OF 110 PARTICIPANTS WILL BE ENROLLED IN THE TRIAL AT EACH STUDY SITE. TRIAL STATUS: PARTICIPANTS' RECRUITMENT STARTED ON 1(ST) MAY 2021. ANTICIPATED END OF RECRUITMENT IS AUGUST 2021. PROTOCOL NUMBER: CCRAS-01 PROTOCOL VERSION NUMBER: 1.1, 13TH JANUARY 2021. TRIAL REGISTRATION: THE TRIAL IS PROSPECTIVELY REGISTERED WITH THE CLINICAL TRIAL REGISTRY OF INDIA (CTRI) ON 03(RD) MARCH 2021 [ CTRI/2021/03/031686 ]. FULL PROTOCOL: THE FULL PROTOCOL IS ATTACHED AS AN ADDITIONAL FILE, ACCESSIBLE FROM THE JOURNAL WEBSITE (ADDITIONAL FILE 1). THIS COMMUNICATION SERVES AS A SUMMARY OF THE KEY ELEMENTS OF THE FULL PROTOCOL. 2021 10 1808 18 PREVENTIVE ASPECT OF AYURVEDA AND YOGA TOWARDS NEWLY EMERGING DISEASE COVID-19. THE ONGOING CORONAVIRUS PANDEMIC IS CAUSED BY SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS COV 2) AND UNIQUE IN VARIOUS FACETS. THE EARLIER EXPERIENCE FROM THE PAST SEVERE ACUTE RESPIRATORY SYNDROME (SARS) EPIDEMICS SEEM TO BE INSUFFICIENT AND THERE IS NEED FOR BETTER STRATEGIES IN PUBLIC HEALTH AND MEDICAL CARE. AYURVED & YOG ARE WELL KNOWN FOR THEIR PREVENTIVE AND THERAPEUTIC ASPECT, BUT NOT GETTING UTILIZED PROPERLY FOR PREVENTION OF COVID 19 CRISIS WHICH MAY ALSO BE HELPFUL AS SUPPORTIVE THERAPY ALONG WITH CURRENT LINE OF MANAGEMENT. THIS PAPER IS AIMED AT UNREVEALING THE ROLE OF AYURVED AND YOGA GUIDELINES ESTABLISHED BY DEPARTMENT OF AYUSH FOR PREVENTION FROM SARS-COV-2 BY PROVIDING HELP TO IMPROVING THE QUALITY OF SUPPORTIVE/PROPHYLACTIC THERAPY IN RELATION WITH THEIR IMMUNITY. 2021 11 2901 19 [ESSENTIAL HYPERTENSION AND STRESS. WHEN DO YOGA, PSYCHOTHERAPY AND AUTOGENIC TRAINING HELP?]. PSYCHOSOCIAL FACTORS PLAY AN IMPORTANT ROLE IN THE DEVELOPMENT AND COURSE OF ESSENTIAL HYPERTENSION, ALTHOUGH "STRESS" CAN ACCOUNT FOR ONLY 10% OF BLOOD PRESSURE VARIANCE. A VARIETY OF PSYCHOTHERAPEUTIC INTERVENTIONS, SUCH AS RELAXATION TECHNIQUES (AUTOGENIC TRAINING OR PROGRESSIVE MUSCULAR RELAXATION), BEHAVIORAL THERAPY OR BIOFEEDBACK TECHNIQUES, CAN LOWER ELEVATED BLOOD PRESSURE BY AN AVERAGE OF 10 MMHG (SYSTOLIC) AND 5 MMHG (DIASTOLIC). AS A "SECONDARY EFFECT", SUCH MEASURES MAY ALSO PROMPT THE HYPERTENSIVE TO ADOPT A MORE HEALTH-CONSCIOUS LIFESTYLE. 2002 12 373 26 AYURVEDA AND YOGA IN CARDIOVASCULAR DISEASES. AYURVEDA IS DERIVED FROM 2 SANSKRIT WORDS, NAMELY, "AYUS" AND "VEDA," MEANING LIFE AND KNOWLEDGE, RESPECTIVELY. IT LITERALLY MEANS SCIENCE OF LIFE. AYURVEDA, OF WHICH YOGA IS AN INTEGRAL PART, IS WIDELY PRACTICED IN INDIA AND IS GAINING ACCEPTANCE IN MANY COUNTRIES AROUND THE WORLD. IT IS A COMPREHENSIVE AND A HOLISTIC SYSTEM, THE FOCUS OF WHICH IS ON THE BODY, MIND, AND CONSCIOUSNESS. THE AYURVEDIC TREATMENT CONSISTS OF THE USE HERBAL PREPARATIONS, DIET, YOGA, MEDITATION, AND OTHER PRACTICES. BASED ON THE REVIEW OF AVAILABLE STUDIES, THE EVIDENCE IS NOT CONVINCING THAT ANY AYURVEDIC HERBAL TREATMENT IS EFFECTIVE IN THE TREATMENT OF HEART DISEASE OR HYPERTENSION. HOWEVER, THE USE OF CERTAIN SPICES AND HERBS SUCH AS GARLIC AND TURMERIC IN AN OVERALL HEALTHY DIET IS APPROPRIATE. MANY HERBS USED BY AYURVEDIC PRACTITIONERS SHOW PROMISE AND COULD BE APPROPRIATE FOR LARGER RANDOMIZED TRIALS. YOGA, AN INTEGRAL PART OF AYURVEDA, HAS BEEN SHOWN TO BE USEFUL TO PATIENTS WITH HEART DISEASE AND HYPERTENSION. YOGA REDUCES ANXIETY, PROMOTES WELL-BEING, AND IMPROVES QUALITY OF LIFE. ITS SAFETY PROFILE IS EXCELLENT. ITS USE AS A COMPLEMENTARY THERAPEUTIC REGIMEN UNDER MEDICAL SUPERVISION IS APPROPRIATE AND COULD BE WORTH CONSIDERING. 2005 13 2715 36 YOGA LIFESTYLE INTERVENTION REDUCES BLOOD PRESSURE IN HIV-INFECTED ADULTS WITH CARDIOVASCULAR DISEASE RISK FACTORS. OBJECTIVE: PEOPLE LIVING WITH HIV INFECTION ARE AT INCREASED RISK FOR DEVELOPING CARDIOVASCULAR DISEASE (CVD). SAFE AND EFFECTIVE INTERVENTIONS FOR LOWERING CVD RISK IN HIV INFECTION ARE HIGH PRIORITIES. WE CONDUCTED A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY TO EVALUATE WHETHER A YOGA LIFESTYLE INTERVENTION IMPROVES CVD RISK FACTORS, VIROLOGICAL OR IMMUNOLOGICAL STATUS, OR QUALITY OF LIFE (QOL) IN HIV-INFECTED ADULTS RELATIVE TO STANDARD OF CARE TREATMENT IN A MATCHED CONTROL GROUP. METHODS: SIXTY HIV-INFECTED ADULTS WITH MILD-MODERATE CVD RISK WERE ASSIGNED TO 20 WEEKS OF SUPERVISED YOGA PRACTICE OR STANDARD OF CARE TREATMENT. BASELINE AND WEEK 20 MEASURES WERE: 2-H ORAL GLUCOSE TOLERANCE TEST WITH INSULIN MONITORING, BODY COMPOSITION, FASTING SERUM LIPID/LIPOPROTEIN PROFILE, RESTING BLOOD PRESSURES, CD4 T-CELL COUNT AND PLASMA HIV RNA, AND THE MEDICAL OUTCOMES STUDY SHORT FORM (SF)-36 HEALTH-RELATED QOL INVENTORY. RESULTS: RESTING SYSTOLIC AND DIASTOLIC BLOOD PRESSURES IMPROVED MORE (P=0.04) IN THE YOGA GROUP (-5 +/- 2 AND -3 +/- 1 MMHG, RESPECTIVELY) THAN IN THE STANDARD OF CARE GROUP (+1 +/- 2 AND+2 +/- 2 MMHG, RESPECTIVELY). HOWEVER, THERE WAS NO GREATER REDUCTION IN BODY WEIGHT, FAT MASS OR PROATHEROGENIC LIPIDS, OR IMPROVEMENTS IN GLUCOSE TOLERANCE OR OVERALL QOL AFTER YOGA. IMMUNE AND VIROLOGICAL STATUS WAS NOT ADVERSELY AFFECTED. CONCLUSION: AMONG TRADITIONAL LIFESTYLE MODIFICATIONS, YOGA IS A LOW-COST, SIMPLE TO ADMINISTER, NONPHARMACOLOGICAL, POPULAR BEHAVIOURAL INTERVENTION THAT CAN LOWER BLOOD PRESSURE IN PRE-HYPERTENSIVE HIV-INFECTED ADULTS WITH MILD-MODERATE CVD RISK FACTORS. 2010 14 811 33 EFFECT OF YOGA ON BLOOD PRESSURE IN PREHYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS. INTRODUCTION: PREHYPERTENSION IS A PRECURSOR FOR DEVELOPING HYPERTENSION AND IS A RISK FACTOR FOR CARDIOVASCULAR DISEASES. YOGA THERAPY MAY HAVE A ROLE IN LOWERING THE BLOOD PRESSURES IN PREHYPERTENSION AND HYPERTENSION. THIS SYSTEMATIC REVIEW AIMS TO SYNTHESIZE THE AVAILABLE LITERATURE FOR THE SAME. METHODOLOGY. DATABASES SUCH AS PUBMED, EMBASE, SCOPUS, AND WEB OF SCIENCE WERE SEARCHED FOR RANDOMISED CONTROL TRIALS ONLY IN THE TIME DURATION OF 2010-2021. THE MAIN OUTCOME OF INTEREST WAS SYSTOLIC AND DIASTOLIC BLOOD PRESSURES. ARTICLES WERE SCREENED BASED ON THE INCLUSION CRITERIA, AND 8 ARTICLES WERE RECRUITED FOR THE REVIEW. META-ANALYSIS WAS DONE FOR SUITABLE ARTICLES. REVMAN 5.4 BY COCHRANE WAS USED FOR META-ANALYSIS AND FOREST PLOT CONSTRUCTION. RISK OF BIAS WAS DETERMINED USING THE DOWNS AND BLACK CHECKLIST BY THREE INDEPENDENT AUTHORS. RESULTS: THE META-ANALYSIS OF THE ARTICLES FAVOURED YOGA INTERVENTION OVER THE CONTROL INTERVENTION. YOGA THERAPY HAD SIGNIFICANTLY REDUCED THE SYSTOLIC PRESSURE (-0.62 STANDARD MEAN DIFFERENCE, AT IV FIXED 95% CI: -0.83, -0.41) AND DIASTOLIC PRESSURE (-0.81 STANDARD MEAN DIFFERENCE, AT IV RANDOM 95% CI: -1.39, -0.22). SECONDARY OUTCOME MEASURES STUDIED WERE HEART RATE, WEIGHT, BMI, WAIST CIRCUMFERENCE, AND LIPID PROFILE. THE MAIN PROTOCOL OF YOGA THERAPY INCLUDED POSTURES, BREATHING EXERCISES, AND DIFFERENT MEDITATION TECHNIQUES. A SIGNIFICANT REDUCTION IN SECONDARY OUTCOMES WAS OBSERVED, EXCEPT FOR HDL VALUES IN LIPID PROFILE WHICH SHOWED A GRADUAL INCREASE IN YOGA GROUP IN COMPARISON WITH ALTERNATIVE THERAPY. CONCLUSION: YOGA THERAPY HAS SHOWN TO BE SIGNIFICANT IN THE REDUCTION OF SYSTOLIC AND DIASTOLIC PRESSURE IN PREHYPERTENSIVE POPULATION. SUPPORTING EVIDENCE LACKS IN PROVIDING A PROPER STRUCTURED DOSAGE OF YOGA ASANAS AND BREATHING TECHNIQUES. CONSIDERING THE EXISTING LITERATURE AND EVIDENCE, YOGA THERAPY CAN BE USED AND RECOMMENDED IN PREHYPERTENSIVE POPULATION AND CAN BE BENEFICIAL IN REDUCING THE CHANCES OF DEVELOPING HYPERTENSION OR CARDIOVASCULAR DISEASES. 2021 15 775 26 EFFECT OF YOGA AND NATUROPATHY ON LIVER, RENAL AND CARDIORESPIRATORY FUNCTIONS OF A PATIENT WITH HEPATIC CIRRHOSIS WITH PORTAL HYPERTENSION AND ASCITES: A CASE REPORT. A 39-YEAR-OLD, MARRIED MAN WAS DIAGNOSED WITH HEPATIC CIRRHOSIS WITH PORTAL HYPERTENSION AND ASCITES IN FEBRUARY 2016. HIS SYMPTOMS AS DESCRIBED BY HIM BEGAN WITH GENERALIZED BODY WEAKNESS, BREATHLESSNESS AND SUDDEN WEIGHT GAIN OF 16KG WITHIN 3 WEEKS. HISTORY OF REGULAR INTAKE OF ALCOHOL SINCE 7 YEARS AND TREMENDOUS FAMILY STRESS WERE PRESENT. PATIENT UNDERWENT CONVENTIONAL MEDICATION FOR 6 MONTHS AND AYURVEDIC MEDICATIONS FOR 4 MONTHS. IN JANUARY 2017, HE VISITED OUR HOSPITAL WITH THE SAME COMPLAINTS AND UNDERWENT INTEGRATED NATUROPATHY AND YOGA THERAPIES (INYTS) FOR 4 WEEKS ALONG WITH AYURVEDA AND CONVENTIONAL MEDICATIONS. THE RESULTS OF THIS STUDY SHOWED A BETTER REDUCTION IN BODY WEIGHT, BODY MASS INDEX, ABDOMINAL GIRTH, SYSTOLIC BLOOD PRESSURE AND DIASTOLIC BLOOD PRESSURE ALONG WITH IMPROVEMENT IN BREATH HOLDING TIME, HEMOGLOBIN LEVEL, LIVER FUNCTION TEST AND RENAL FUNCTION TEST. IT SUGGESTS THAT 4 WEEKS OF INYT WITH AYURVEDA AND CONVENTIONAL MEDICATIONS WAS EFFECTIVE IN PATIENTS WITH HEPATIC CIRRHOSIS WITH PORTAL HYPERTENSION AND ASCITES. FURTHER STUDIES ARE REQUIRED TO WARRANT THESE RESULTS. 2018 16 1936 19 ROLE OF YOGA IN THE PREVENTION AND MANAGEMENT OF VARIOUS CARDIOVASCULAR DISEASES AND THEIR RISK FACTORS: A COMPREHENSIVE SCIENTIFIC EVIDENCE-BASED REVIEW. CARDIOVASCULAR DISEASES (CVDS) ARE A GROUP OF DISORDERS OF THE HEART AND BLOOD VESSELS. CVDS ARE THE LEADING CAUSE OF DEATHS WORLDWIDE. THOUGH YOGA IS GAINING POPULARITY AS A THERAPY, ESPECIALLY IN CVD PATIENTS, THERE IS A LACK OF A COMPREHENSIVE REVIEW REPORTING ITS ROLE IN THE MANAGEMENT OF VARIOUS CVDS AND THEIR RISK FACTORS. THUS, WE PERFORMED A COMPREHENSIVE LITERATURE SEARCH IN THE PUBMED/MEDLINE ELECTRONIC DATABASE. AN AGGREGATE OF 603 ARTICLES PUBLISHED FROM INCEPTION WERE SCREENED AND 85 ARTICLES THAT ARE APPLICABLE WERE REPORTED. THIS REVIEW SUGGESTS THAT YOGA MAY PLAY A ROLE AS AN ADJUVANT IN THE MANAGEMENT OF VARIOUS CVDS AND THEIR RISK FACTORS. HOWEVER, MANY STUDIES HAD A SMALL SAMPLE SIZE, DIFFERENT TYPES AND DURATIONS OF THE YOGA INTERVENTIONS, AND DID NOT PROVIDE THE DETAILS OF MECHANISMS BEHIND THE IMPROVEMENTS. THUS, FURTHER STUDIES ARE WARRANTED TO EXPLORE THE MECHANISMS OF THE IMPACTS OF YOGA. 2020 17 2196 28 THE EFFICACY AND SAFETY OF YOGA IN MANAGING HYPERTENSION. HYPERTENSION IS A MAJOR PUBLIC HEALTH PROBLEM AND ONE OF THE MOST IMPORTANT CAUSES OF PREMATURE MORBIDITY AND MORTALITY. YOGA IS A TRADITIONAL INDIAN PRACTICE THAT HAS BEEN ADAPTED FOR USE IN COMPLEMENTARY AND ALTERNATIVE MEDICINE AND MAINLY INCLUDES PHYSICAL POSTURES, BREATHING TECHNIQUES, AND MEDITATION. THE IMPACT OF YOGA AS A COMPLEMENTARY INTERVENTION FOR HYPERTENSION HAS BEEN INVESTIGATED IN A NUMBER OF RANDOMIZED CONTROLLED TRIALS; WITH AN OVERALL EFFECT OF ABOUT 10 MMHG REDUCTION IN SYSTOLIC AND ABOUT 8 MMHG REDUCTION IN DIASTOLIC BLOOD PRESSURE. YOGA SEEMS TO BE EFFECTIVE ONLY FOR HYPERTENSION BUT NOT FOR PREHYPERTENSION; AND ONLY AS AN ADJUNCT TO ANTIHYPERTENSIVE PHARMACOLOGICAL TREATMENT BUT NOT AS AN ALTERNATIVE THERAPY. BREATHING AND MEDITATION RATHER THAN PHYSICAL ACTIVITY SEEM TO BE THE ACTIVE PART OF YOGA INTERVENTIONS FOR HYPERTENSIVE PATIENTS. THESE PRACTICES CAN INCREASE PARASYMPATHIC ACTIVITY AND DECREASE SYMPATHETIC ACTIVITY, ARGUABLY MAINLY BY INCREASING GABA ACTIVITY; THUS COUNTERACTING EXCESS ACTIVITY OF THE SYMPATHETIC NERVOUS SYSTEM WHICH HAS BEEN ASSOCIATED WITH HYPERTENSION. ALTHOUGH YOGA HAS BEEN ASSOCIATED WITH SERIOUS ADVERSE EVENTS IN SINGLE CASE REPORTS, POPULATION-BASED SURVEYS AS WELL AS CLINICAL TRIALS INDICATE THAT YOGA IS A RELATIVELY SAFE INTERVENTION THAT IS NOT ASSOCIATED WITH MORE ADVERSE EVENTS THAN OTHER FORMS OF PHYSICAL ACTIVITY. YOGA CAN THUS BE CONSIDERED A SAFE AND EFFECTIVE INTERVENTION FOR MANAGING HYPERTENSION. GIVEN THE POSSIBLY BETTER RISK/BENEFIT RATIO, IT MAY BE ADVISABLE TO FOCUS ON YOGIC MEDITATION AND/OR BREATHING TECHNIQUES. 2016 18 1928 23 ROLE OF YOGA IN DIABETES. THE SCIENCE OF YOGA IS AN ANCIENT ONE. IT IS A RICH HERITAGE OF OUR CULTURE. SEVERAL OLDER BOOKS MAKE A MENTION OF THE USEFULNESS OF YOGA IN THE TREATMENT OF CERTAIN DISEASES AND PRESERVATION OF HEALTH IN NORMAL INDIVIDUALS. THE EFFECT OF YOGIC PRACTICES ON THE MANAGEMENT OF DIABETES HAS NOT BEEN INVESTIGATED WELL. WE CARRIED OUT WELL DESIGNED STUDIES IN NORMAL INDIVIDUALS AND THOSE WITH DIABETES TO ASSESS THE ROLE OF YOGIC PRACTICES ON GLYCAEMIC CONTROL, INSULIN KINETICS, BODY COMPOSITION EXERCISE TOLERANCE AND VARIOUS CO-MORBIDITIES LIKE HYPERTENSION AND DYSLIPIDEMIA. THESE STUDIES WERE BOTH SHORT TERM AND LONG-TERM. THESE STUDIES HAVE CONFIRMED THE USEFUL ROLE OF YOGA IN THE CONTROL OF DIABETES MELLITUS. FASTING AND POSTPRANDIAL BLOOD GLUCOSE LEVELS CAME DOWN SIGNIFICANTLY. GOOD GLYCAEMIC STATUS CAN BE MAINTAINED FOR LONG PERIODS OF TIME. THERE WAS A LOWERING OF DRUG REQUIREMENT AND THE INCIDENCE OF ACUTE COMPLICATIONS LIKE INFECTION AND KETOSIS WAS SIGNIFICANTLY REDUCED. THERE WERE SIGNIFICANT CHANGES IN THE INSULIN KINETICS AND THOSE OF COUNTER-REGULATORY HORMONES LIKE CORTISOL. THERE WAS A DECREASE IN FREE FATTY ACIDS. THERE WAS AN INCREASE IN LEAN BODY MASS AND DECREASE IN BODY FAT PERCENTAGE. THE NUMBER OF INSULIN RECEPTORS WAS ALSO INCREASED. THERE WAS AN IMPROVEMENT IN INSULIN SENSITIVITY AND DECLINE IN INSULIN RESISTANCE. ALL THESE SUGGEST THAT YOGIC PRACTICES HAVE A ROLE EVEN IN THE PREVENTION OF DIABETES. THERE IS A BENEFICIAL EFFECT ON THE CO-MORBID CONDITIONS LIKE HYPERTENSION AND DYSLIPIDEMIA. 2007 19 1664 20 NATUROPATHY AND YOGA AS AN ADJUVANT FOR PEOPLE LIVING WITH HIV/AIDS - A CASE SERIES REPORT. HUMAN IMMUNODEFICIENCY VIRUS (HIV) IS AN INFECTION THAT POSES A GREAT THREAT TO BOTH DEVELOPED AND DEVELOPING COUNTRIES. HEALTH FACILITIES OFFERING COMPLEMENTARY CARE, ALONG WITH STANDARD CARE, HAVE BEEN CONSIDERED AS A USEFUL STRATEGY TO OVERCOME THE BURDEN OF HIV AND PROMOTE QUALITY AND WELLBEING AMONG PEOPLE LIVING WITH HIV/AIDS (PLWHA). IN THIS REPORT, WE MAKE REFERENCE TO SEVEN PARTICIPANTS DIAGNOSED WITH HIV, WHO UNDERWENT NATUROPATHY AND YOGA BASED LIFESTYLE INTERVENTION (NYLI), FOR VARYING DURATIONS, AT A SANATORIUM FOR PLWHA. THE CASES SUGGEST THAT NYLI FUNCTIONS AS AN ADJUVANT THERAPY THAT COMPLEMENTS STANDARD CARE, IMPROVES ADHERENCE AND PROMOTES HEALTH-RELATED OUTCOMES IN HIV AFFILIATED CLINICAL MARKERS, SUCH AS HAEMOGLOBIN, WEIGHT AND CD4+ COUNTS. HOWEVER, FURTHER CONTROLLED TRIALS ARE REQUIRED TO ESTABLISH WARRANTING EVIDENCE. 2019 20 1187 28 EVIDENCE BASED EFFECTS OF YOGA PRACTICE ON VARIOUS HEALTH RELATED PROBLEMS OF ELDERLY PEOPLE: A REVIEW. MORE THAN 50% OF THE ELDERLY ABOVE 60 YEARS OF AGE SUFFER FROM CHRONIC MEDICAL CONDITIONS, THE PREVALENCE OF WHICH INCREASES WITH AGE. THOUGH YOGA HAS BEEN REPORTED AS AN EFFECTIVE MODALITY IN IMPROVING VARIOUS PHYSICAL AND PSYCHOLOGICAL ASPECTS OF ELDERLY POPULATIONS, A COMPREHENSIVE REVIEW OF YOGA AND ITS EFFECTS ON VARIOUS HEALTH RELATED PROBLEMS OF ELDERLY POPULATIONS HAS NOT YET BEEN REPORTED. HENCE, WE PERFORMED PUBMED/MEDLINE SEARCH TO REVIEW RELEVANT ARTICLES, USING KEYWORD "YOGA AND ELDERLY". RELEVANT ARTICLES PUBLISHED SINCE INCEPTION TILL 6TH OCTOBER 2016 WERE INCLUDED FOR THE REVIEW. BASED ON THE AVAILABLE SCIENTIFIC LITERATURE, THIS REVIEW SUGGESTS THAT THE REGULAR PRACTICE OF YOGA CAN BE CONSIDERED AS AN EFFECTIVE INTERVENTION IN IMPROVING PHYSICAL (REDUCES HEART RATE, BLOOD PRESSURE, BLOOD GLUCOSE, OXIDATIVE DAMAGE, FATIGUE, WEAKNESS, FEAR OF FALL, AND IMPROVE HEART RATE VARIABILITY, BAROREFLEX SENSITIVITY, INSULIN SENSITIVITY, PHYSICAL FUNCTIONS, MOBILITY, FLEXIBILITY, AND URINARY INCONTINENCE), MENTAL (REDUCES DEPRESSION, ANXIETY), EMOTIONAL (REDUCES ANGER, STRESS, TENSION AND IMPROVE SELF-EFFICACY), SOCIAL (IMPROVE LIFE SATISFACTION), AND VITAL (IMPROVED VITALITY) PLANES OF ELDERLY INDIVIDUALS, OFFERING A BETTER QUALITY OF SLEEP AND QUALITY OF LIFE. 2017